How much revenue does Isracann Biosciences make?

Isracann Biosciences reported 0 CAD in revenue for fiscal year 2022. In Q1 2023 revenue was 0 CAD.

What companies are similar to Isracann Biosciences?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Millennium Investment & Acquisition Company Inc. (MILC), Green Growth Brands Inc. (GGBXF), Fiore Cannabis Ltd. (FIORF), RegeneRx Biopharmaceuticals, Inc. (RGRX).

Isracann Biosciences Inc. (ISCNF) Stock

About Isracann Biosciences Inc.

Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in V...

At a glance

Isracann Biosciences reported revenue of 0 CAD for fiscal year 2022, and net income of -4.69 million CAD. In Q1 2023 (the quarter ended August 31, 2022) revenue was 0 CAD.

Figures from company filings; latest fiscal year ended May 31, 2022.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.